{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:49:49Z","timestamp":1757616589858,"version":"3.44.0"},"reference-count":9,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Fam Plann Reprod Health Care"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1783\/147118910791749498","type":"journal-article","created":{"date-parts":[[2010,7,8]],"date-time":"2010-07-08T19:36:20Z","timestamp":1278617780000},"page":"181.1-181","source":"Crossref","is-referenced-by-count":3,"title":["Query about Faculty updated UKMEC"],"prefix":"10.1136","volume":"36","author":[{"given":"Deborah J","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2010,7,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1783\/147118910791749498","article-title":"Query about updated UKMEC (Letter)","volume":"36","author":"Lee, D.J.","year":"2010","unstructured":"Lee DJ. Query about updated UKMEC (Letter). J Fam Plann Reprod Health Care 2010; 36: 181.","journal-title":"J Fam Plann Reprod Health Care"},{"key":"ref_2","article-title":"UK Medical Eligibility Criteria for Contraceptive Use","author":"of Sexual, Faculty; Healthcare, Reproductive","year":"2009","unstructured":"Faculty of Sexual and Reproductive Healthcare. UK Medical Eligibility Criteria for Contraceptive Use (UKMEC 2009). 2009. http:\/\/www.fsrh.org\/admin\/uploads\/UKMEC2009.pdf [Accessed 10 March 2010]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.contraception.2007.11.012","article-title":"Much ado about little: obesity, combined hormonal contraceptive use and venous thrombosis","volume":"77","author":"Trussell, J.; Guthrie, K.; Schwarz, E.B.","year":"2008","unstructured":"Trussell J, Guthrie K, Schwarz EB. Much ado about little: obesity, combined hormonal contraceptive use and venous thrombosis. Contraception 2008; 77: 143\u2013146.","journal-title":"Contraception"},{"key":"ref_4","article-title":"A 33-year-old woman, para 3, attended in May 2007, requesting termination of pregnancy. She had an Implanon since July 2004 and was amenorrhoeic until February 2007. She was commenced on Sustiva\u00ae (efavirenz 600 mg tab) and Truvada\u00ae","volume-title":"and tenofovir disoproxil 245 mg) in January 2007 as her HIV viral load was rising. She was not asked and did not volunteer Implanon use. Concerns for the adverse effect of the ARVs on the fetus had prompted the termination request. After a normal dating ultrasound scan her decision to terminate became ambivalent. She became committed to the pregnancy after a normal 15-week scan and delivered a male baby weighing 3520 g at term","year":"(emtricitabine 200 mg","unstructured":"A 33-year-old woman, para 3, attended in May 2007, requesting termination of pregnancy. She had an Implanon since July 2004 and was amenorrhoeic until February 2007. She was commenced on Sustiva\u00ae (efavirenz 600 mg tab) and Truvada\u00ae (emtricitabine 200 mg and tenofovir disoproxil 245 mg) in January 2007 as her HIV viral load was rising. She was not asked and did not volunteer Implanon use. Concerns for the adverse effect of the ARVs on the fetus had prompted the termination request. After a normal dating ultrasound scan her decision to terminate became ambivalent. She became committed to the pregnancy after a normal 15-week scan and delivered a male baby weighing 3520 g at term."},{"key":"ref_5","unstructured":"These cases highlight the unforeseen consequences of non-disclosure of HIV for both patients and physicians. One of the dilemmas facing physicians is whether to disclose the HIV diagnosis to general practitioners (GPs). Arguments have been advanced for specialists breaching confidentiality and notifying the GP against patients\u2019 wishes in the interest of normal medical practice, the patients\u2019 and health personnel best interests, and the interests of society in general. Gillon4 examines each argument and concludes that none is sufficient to justify violating physician patient confidentiality in most cases.","article-title":"These cases highlight the unforeseen consequences of non-disclosure of HIV for both patients and physicians. One of the dilemmas facing physicians is whether to disclose the HIV diagnosis to general practitioners (GPs). Arguments have been advanced for specialists breaching confidentiality and notifying the GP against patients\u2019 wishes in the interest of normal medical practice, the patients\u2019 and health personnel best interests, and the interests of society in general. Gillon4 examines each argument and concludes that none is sufficient to justify violating physician patient confidentiality in most cases"},{"key":"ref_6","first-page":"139","article-title":"Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit","volume":"31","year":"2005","unstructured":"Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. FFPRHC Guidance (April 2005). Drug interactions with hormonal contraception. J Fam Plann Reprod Health Care 2005; 31: 139\u2013151.","journal-title":"Drug interactions with hormonal contraception; J Fam Plann Reprod Health Care"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/14730782.2000.12288981","article-title":"The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant","volume":"5","author":"Bennink, H.J.","year":"2000","unstructured":"Bennink HJ. The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant. Eur J Contracept Reprod Health Care 2000; 5(Suppl. 2): 12\u201320.","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"6","key":"ref_8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0010-7824(98)00118-8","article-title":"The pharmacodynamics and efficacy of Implanon. An overview of the data","volume":"58","year":"1998","unstructured":"Croxatto HB, M\u00e4k\u00e4r\u00e4inen L. The pharmacodynamics and efficacy of Implanon. An overview of the data. Contraception 1998; 58(6 Suppl.): 91S\u201397S.","journal-title":"Contraception"},{"issue":"3","key":"ref_9","article-title":"Fam Plann Reprod","volume":"36","author":"FSRH, J.","year":"2010","unstructured":"\u00a9FSRH J Fam Plann Reprod Health Care 2010: 36(3)","journal-title":"Health Care"}],"container-title":["Journal of Family Planning and Reproductive Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1783\/147118910791749498","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T19:07:23Z","timestamp":1757099243000},"score":1,"resource":{"primary":{"URL":"https:\/\/jfprhc.bmj.com\/lookup\/doi\/10.1783\/147118910791749498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":9,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2010,7,1]]},"published-print":{"date-parts":[[2010,7]]}},"alternative-id":["10.1783\/147118910791749498"],"URL":"https:\/\/doi.org\/10.1783\/147118910791749498","relation":{},"ISSN":["1471-1893","2045-2098"],"issn-type":[{"type":"print","value":"1471-1893"},{"type":"electronic","value":"2045-2098"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}